MODE OF ACTION & TRIAL RESULTS
• POWERFUL IMMUNITY & PATHOGEN INHIBITION
Manufactured via unique enzymatic hydrolysis, RFC technology delivers >90% dependent inhibition against Vibrio parahaemolyticus strains (the primary cause of AHPND/EMS in shrimp) and cuts mortality rates in half compared to control groups.
• INTESTINAL MORPHOLOGY & GUT HEALTH
Optimizes gut morphology and microbiota stability in tilapia and other commercial fish species. Expands nutrient absorption areas to secure an enhanced Feed Conversion Ratio (FCR).
• PEAK PERFORMANCE & FILLET YIELD
As proven in a 90-day tilapia trial, it accelerates average live body-weight gain and provides a statistically critical boost (approx. 4.3%) in total fillet yield.
KEY ADVANTAGES
- Supports overall intestinal health and ramps up internal natural immune systems.
- Improves flock survival rates significantly under challenging environmental or disease stress.
- Maximizes feed utilization values to lower overall production investments.
- Broad spectrum suitability for Olive Flounder, Eels, Catfish, and Artemia setups.
RECOMMENDED DOZAGES
| Product Form |
Recommended Dosage |
| RFR-Celmanax Aqua (Liquid) |
With Water: 100 ppm / With Feed: 200 ppm |
| RFR-Celmanax SCP (Powder) |
In Feed: 100 g / ton |
* Double dosing is advised during high-challenge or acute health crises conditions.
